Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Dr. Guillaume Canaud at the Necker-Enfants Malades Hospital and his team recently demonstrated the efficacy of a specific inhibitor called BYL719 in a cohort of 19 patients suffering from congenital lipomatous overgrowth-vascular ...
Jun 15, 2018
0
1